Roman Butler Fullerton & Co »

Krystal Biotech shares owned by Roman Butler Fullerton & Co

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Roman Butler Fullerton & Co from 13F filings

Historical chart of Roman Butler Fullerton & Co investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Roman Butler Fullerton & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Roman Butler Fullerton & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $325k 1.1k 289.13
2025-03-31 $654k 3.9k 169.13

More positions owned by Roman Butler Fullerton & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Wal-Mart Stores (WMT)
Mastercard Incorporated Cl A (MA)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Growth Etf (VUG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Cigna Corp (CI)
Eaton Vance Enhanced Equity Income Fund (EOI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Roman Butler Fullerton & Co

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Group
State Street Corporation
Soleus Capital Management
Capital World Investors
Citadel Advisors
Redmile Group
Hood River Capital Management
Geode Capital Management
Dimensional Fund Advisors
Frazier Life Sciences Management
Bellevue Group
William Blair Investment Management

View all funds holding Krystal Biotech